Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells. read more

EMPLOYEE PARTICIPANTS: 66

TOTAL RATINGS: 732

CEO: Stéphane Bancel

HR or Marketing? Claim Your Free Employer Account

Stéphane Bancel Moderna Therapeutics CEO Rating

Moderna Therapeutics' CEO, Stéphane Bancel, has 63 employee ratings and a score of 50/100, placing them in the Bottom 10% of similar size companies on Comparably with 51-200 Employees and Bottom 5% of other companies in Boston. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Moderna Therapeutics rate Stéphane Bancel higher than females, giving the CEO a score of 77/100.

Last updated a month ago.

Where This Score Ranks Moderna Therapeutics' CEO Rating

BOTTOM
10%
In the Bottom 10% of 2035 Similar Sized Companies on Comparably
BOTTOM
5%
In the Bottom 5% of 270 Nearby Companies in Boston
4th
4th place versus 4 competitors rated on Comparably

Feb

May

Jul

Sep

Oct

D-50 / 100

Jan

Moderna Therapeutics CEO Stéphane Bancel Bio

Stéphane Bancel serves as the CEO / President of Moderna Therapeutics.

Who Ranks Moderna Therapeutics' CEO Rating the Highest?

Ethnicity - Caucasian 83/100

Gender - Male 77/100

Experience - Over 10 Years 67/100

Who Ranks Moderna Therapeutics' CEO Rating the Lowest?

Tenure - 1 to 2 Years 60/100

Gender - Female 65/100

Moderna Therapeutics CEO Stéphane Bancel At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Moderna Therapeutics.

Based on 63 ratings, Stéphane Bancel ranks right below RaNA Therapeutics' CEO, Ronald Renaud.

Moderna Therapeutics' CEO is highly regarded by Caucasian employees, Male employees, and employees with Over 10 Years experience. However, employees who have been at the company 1 to 2 Years and Female employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.